Virbac Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

Virbac heeft een totaal eigen vermogen van €994.2M en een totale schuld van €370.0M, wat de schuld-eigenvermogensverhouding op 37.2% brengt. De totale activa en totale passiva bedragen respectievelijk €1.8B en €802.0M. De EBIT Virbac is €227.3M waardoor de rentedekking 87.6 is. Het heeft contanten en kortetermijnbeleggingen van €158.6M.

Belangrijke informatie

37.2%

Verhouding schuld/eigen vermogen

€369.96m

Schuld

Rente dekkingsratio87.6x
Contant€158.64m
Aandelen€994.24m
Totaal verplichtingen€801.99m
Totaal activa€1.80b

Recente financiële gezondheidsupdates

Recent updates

An Intrinsic Calculation For Virbac SA (EPA:VIRP) Suggests It's 47% Undervalued

Oct 06
An Intrinsic Calculation For Virbac SA (EPA:VIRP) Suggests It's 47% Undervalued

Virbac SA Just Beat Revenue Estimates By 6.0%

Sep 18
Virbac SA Just Beat Revenue Estimates By 6.0%

Unpleasant Surprises Could Be In Store For Virbac SA's (EPA:VIRP) Shares

Aug 31
Unpleasant Surprises Could Be In Store For Virbac SA's (EPA:VIRP) Shares

Why We Think Virbac SA's (EPA:VIRP) CEO Compensation Is Not Excessive At All

Jun 15
Why We Think Virbac SA's (EPA:VIRP) CEO Compensation Is Not Excessive At All

Are Investors Undervaluing Virbac SA (EPA:VIRP) By 34%?

Jun 10
Are Investors Undervaluing Virbac SA (EPA:VIRP) By 34%?

Virbac SA (EPA:VIRP) Investors Are Less Pessimistic Than Expected

May 21
Virbac SA (EPA:VIRP) Investors Are Less Pessimistic Than Expected

Here's What Analysts Are Forecasting For Virbac SA (EPA:VIRP) After Its Yearly Results

Mar 22
Here's What Analysts Are Forecasting For Virbac SA (EPA:VIRP) After Its Yearly Results

Is Virbac SA (EPA:VIRP) Trading At A 23% Discount?

Jan 18
Is Virbac SA (EPA:VIRP) Trading At A 23% Discount?

Virbac SA's (EPA:VIRP) Shares Climb 25% But Its Business Is Yet to Catch Up

Dec 27
Virbac SA's (EPA:VIRP) Shares Climb 25% But Its Business Is Yet to Catch Up

Virbac (EPA:VIRP) Has A Pretty Healthy Balance Sheet

Oct 19
Virbac (EPA:VIRP) Has A Pretty Healthy Balance Sheet

Is There An Opportunity With Virbac SA's (EPA:VIRP) 40% Undervaluation?

Sep 26
Is There An Opportunity With Virbac SA's (EPA:VIRP) 40% Undervaluation?

Here's Why We Think Virbac (EPA:VIRP) Is Well Worth Watching

Sep 05
Here's Why We Think Virbac (EPA:VIRP) Is Well Worth Watching

A Look At The Fair Value Of Virbac SA (EPA:VIRP)

Jun 20
A Look At The Fair Value Of Virbac SA (EPA:VIRP)

Does Virbac (EPA:VIRP) Deserve A Spot On Your Watchlist?

May 31
Does Virbac (EPA:VIRP) Deserve A Spot On Your Watchlist?

Is Virbac (EPA:VIRP) Using Too Much Debt?

Apr 09
Is Virbac (EPA:VIRP) Using Too Much Debt?

Are Investors Undervaluing Virbac SA (EPA:VIRP) By 34%?

Feb 28
Are Investors Undervaluing Virbac SA (EPA:VIRP) By 34%?

Virbac SA (EPA:VIRP) Shares Could Be 50% Below Their Intrinsic Value Estimate

Nov 25
Virbac SA (EPA:VIRP) Shares Could Be 50% Below Their Intrinsic Value Estimate

Does Virbac (EPA:VIRP) Have A Healthy Balance Sheet?

Oct 14
Does Virbac (EPA:VIRP) Have A Healthy Balance Sheet?

An Intrinsic Calculation For Virbac SA (EPA:VIRP) Suggests It's 42% Undervalued

Aug 07
An Intrinsic Calculation For Virbac SA (EPA:VIRP) Suggests It's 42% Undervalued

These 4 Measures Indicate That Virbac (EPA:VIRP) Is Using Debt Safely

Jun 26
These 4 Measures Indicate That Virbac (EPA:VIRP) Is Using Debt Safely

Virbac SA (EPA:VIRP) Shares Could Be 38% Below Their Intrinsic Value Estimate

May 01
Virbac SA (EPA:VIRP) Shares Could Be 38% Below Their Intrinsic Value Estimate

We Think Virbac (EPA:VIRP) Can Manage Its Debt With Ease

Mar 26
We Think Virbac (EPA:VIRP) Can Manage Its Debt With Ease

Virbac SA (EPA:VIRP) Shares Could Be 36% Below Their Intrinsic Value Estimate

Jan 26
Virbac SA (EPA:VIRP) Shares Could Be 36% Below Their Intrinsic Value Estimate

Here's Why I Think Virbac (EPA:VIRP) Is An Interesting Stock

Dec 28
Here's Why I Think Virbac (EPA:VIRP) Is An Interesting Stock

A Look At The Fair Value Of Virbac SA (EPA:VIRP)

Oct 27
A Look At The Fair Value Of Virbac SA (EPA:VIRP)

Is Virbac (EPA:VIRP) Using Too Much Debt?

Oct 12
Is Virbac (EPA:VIRP) Using Too Much Debt?

Here's Why I Think Virbac (EPA:VIRP) Might Deserve Your Attention Today

Sep 26
Here's Why I Think Virbac (EPA:VIRP) Might Deserve Your Attention Today

Is Virbac SA (EPA:VIRP) Trading At A 22% Discount?

Jul 15
Is Virbac SA (EPA:VIRP) Trading At A 22% Discount?

Is Now The Time To Put Virbac (EPA:VIRP) On Your Watchlist?

Jun 27
Is Now The Time To Put Virbac (EPA:VIRP) On Your Watchlist?

Is Virbac (EPA:VIRP) A Risky Investment?

May 27
Is Virbac (EPA:VIRP) A Risky Investment?

Robust Earnings May Not Tell The Whole Story For Virbac (EPA:VIRP)

Mar 24
Robust Earnings May Not Tell The Whole Story For Virbac (EPA:VIRP)

Are Investors Undervaluing Virbac SA (EPA:VIRP) By 32%?

Mar 12
Are Investors Undervaluing Virbac SA (EPA:VIRP) By 32%?

Here's Why We Think Virbac (EPA:VIRP) Is Well Worth Watching

Feb 22
Here's Why We Think Virbac (EPA:VIRP) Is Well Worth Watching

Is Virbac SA (EPA:VIRP) Popular Amongst Insiders?

Feb 03
Is Virbac SA (EPA:VIRP) Popular Amongst Insiders?

Virbac SA's (EPA:VIRP) Stock Is Going Strong: Is the Market Following Fundamentals?

Jan 05
Virbac SA's (EPA:VIRP) Stock Is Going Strong: Is the Market Following Fundamentals?

Does Virbac's (EPA:VIRP) Share Price Gain of 96% Match Its Business Performance?

Dec 18
Does Virbac's (EPA:VIRP) Share Price Gain of 96% Match Its Business Performance?

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( €877.3M ) VIRP } overtreffen de korte termijn passiva ( €530.6M ).

Langlopende schulden: De kortetermijnactiva VIRP ( €877.3M ) overtreffen de langetermijnschulden ( €271.4M ).


Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: De netto schuld/eigen vermogen ratio ( 21.3% ) VIRP wordt als voldoende beschouwd.

Schuld verminderen: De schuld/eigen vermogen-ratio van VIRP is de afgelopen 5 jaar gedaald van 94.1% naar 37.2%.

Schuldendekking: De schuld van VIRP wordt goed gedekt door de operationele kasstroom ( 37.5% ).

Rentedekking: De rentebetalingen op de schuld van VIRP worden goed gedekt door EBIT ( 87.6 x dekking).


Balans


Ontdek gezonde bedrijven